| http://www.w3.org/ns/prov#value | - In our view, CSF biomarkers might be especially important to be able to start treatment early in the course of the disease, when age-associated memory impairment and depressive pseudodementia are some of the most problematic differential diagnoses.35 In a recent study,36 we showed that the combination of CSF-tau and CSF-A??42 also might help identify patients with MCI who will develop AD.
|
